Generation of a NONO homozygous knockout human induced pluripotent stem cell line by CRISPR/Cas9 editing

被引:2
|
作者
Yi, Tong
Bai, Rui
Sun, Hairui
Lan, Feng
Zhang, Hongjia
He, Yihua
机构
[1] Capital Med Univ, Beijing Anzhen Hosp, Beijing Key Lab Maternal Fetal Med & Fetal Heart, Beijing, Peoples R China
[2] Minist Educ, Key Lab Remodeling Related Cardiovasc Dis, Beijing Lab Cardiovasc Precis Med, Beijing, Peoples R China
[3] Capital Med Univ, Anzhen Hosp, Collaborat Innovat Ctr Cardiovasc Disorders, Beijing 100029, Peoples R China
基金
国家重点研发计划;
关键词
D O I
10.1016/j.scr.2020.101893
中图分类号
Q813 [细胞工程];
学科分类号
摘要
The non-POU domain containing octamer-binding gene (NONO) encodes a member of a small family of RNA-binding and DNA-binding proteins, whose variants can cause intellectual disability and congenital heart defects. In this study, we generated a homozygous NONO knockout (NONO-KO) induced pluripotent stem cell (iPSC) line (CMUi002-A-1) using the CRISPR/Cas9-based genome editing system. The gene-edited line had a normal karyotype, expressed pluripotency markers, and was able to differentiate into all three germ layers in vivo. This cell line will provide a platform to study the pathogenic mechanisms of noncompaction cardiomyopathy and neurocyte dysfunction related to NONO mutations.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Generation of a homozygous ZBTB7A knockout human induced pluripotent stem line by CRISPR/Cas9 editing
    Chen, Diyu
    Song, Bing
    Cheng, Yi
    Zhu, Lifen
    Lu, Dian
    Liu, Nengqing
    Yang, Yinghong
    Sun, Xiaofang
    [J]. STEM CELL RESEARCH, 2021, 55
  • [2] Generation of a TLR7 homozygous knockout human induced pluripotent stem cell line using CRISPR/Cas9
    Han, Hyeong-jun
    Seo, Hyang-Hee
    Han, Hyo-Won
    Kim, Jung-Hyun
    [J]. STEM CELL RESEARCH, 2019, 40
  • [3] Generation of a homozygous HDAC6 knockout human embryonic stem cell line by CRISPR/Cas9 editing
    Xie, Liangqun
    Huang, Jingrui
    Li, Xun
    Dai, Lei
    Lin, Xinxiu
    Zhang, Jiejie
    Luo, Jiefeng
    Zhang, Weishe
    [J]. STEM CELL RESEARCH, 2019, 41
  • [4] Generation of a TPM1 homozygous knockout embryonic stem cell line by CRISPR/Cas9 editing
    Ma, Shuhong
    Xu, Qi
    Bai, Rui
    Dong, Tao
    Peng, Zhiping
    Liu, Xujie
    [J]. STEM CELL RESEARCH, 2021, 55
  • [5] Generation of an NANS homozygous knockout human induced pluripotent stem cell line by the insertion of GFP-P2A-Puro via CRISPR/Cas9 editing
    Bu, Qian
    Zhang, Huaqin
    Liu, Qian
    Dai, Yanping
    Wei, Qian
    Xue, Aiqin
    Huang, Yan
    Zhong, Kai
    Huang, Yina
    Gao, Hong
    Cen, Xiaobo
    [J]. STEM CELL RESEARCH, 2020, 49
  • [6] Generation of homozygous and heterozygous REEP1 knockout induced pluripotent stem cell lines by CRISPR/Cas9 gene editing
    Korneck, M.
    Leonhardt, A.
    Schoels, L.
    Hauser, S.
    [J]. STEM CELL RESEARCH, 2024, 77
  • [7] Generation of a MIR5004 knockout cell line from human induced pluripotent stem cells by CRISPR/Cas9 gene editing
    Gulimiheranmu, Maisumu
    Li, Shuang
    Zhou, Junmei
    [J]. STEM CELL RESEARCH, 2022, 62
  • [8] Establishment of a TLR3 homozygous knockout human induced pluripotent stem cell line using CRISPR/Cas9
    Han, Hyeong-jun
    Kim, Jung-Hyun
    [J]. STEM CELL RESEARCH, 2021, 52
  • [9] Generation of a TLR2 knockout human induced pluripotent stem cell line using CRISPR/Cas9
    Han, Hyeong-Jun
    Kim, Jung-Hyun
    [J]. STEM CELL RESEARCH, 2021, 57
  • [10] Generation of a SMO homozygous knockout human embryonic stem cell line WAe001-A-16 by CRISPR/Cas9 editing
    Wu, Feima
    Gao, Ge
    Pan, Tingcai
    Yang, Zhen
    Xu, Guosheng
    Abbas, Nasir
    Liu, Yanli
    Chen, Yan
    Tan, Shenglin
    You, Kai
    Ke, Xinrong
    Zhuang, Yuanqi
    Lin, Xianhua
    Yang, Fan
    Li, Yin-xiong
    [J]. STEM CELL RESEARCH, 2018, 27 : 5 - 9